Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 28, Number 7—July 2022
Research Letter

Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain

Alex Wing Hong ChinComments to Author , Alison Man Yuk Lai, Malik Peiris, and Leo Lit Man PoonComments to Author 
Author affiliations: The University of Hong Kong, Hong Kong, China (A.W.H. Chin, A.M.Y. Lai, M. Peiris, L.L.M. Poon); Centre for Immunology & Infection, Hong Kong (A.W.H. Chin, M. Peiris, L.L.M. Poon)

Suggested citation for this article

Abstract

As of April 2022, the Omicron BA.1 variant of concern of SARS-CoV-2 was spreading quickly around the world and outcompeting other circulating strains. We examined its stability on various surfaces and found that this Omicron variant is more stable than its ancestral strain on smooth and porous surfaces.

The Omicron SARS-CoV-2 variant of concern (VOC) is highly transmissible in humans. As of April 2022, it has outcompeted other known variants and dominated in different regions (1). Its spike protein has >30 mutations compared with the ancestral strain (2). A 2022 structural study indicates the Omicron spike protein is more stable than that of the ancestral strain (3); this finding prompted us to hypothesize that Omicron VOC is also more stable on different surfaces. We previously showed that the ancestral SARS-CoV-2 strain can still be infectious at room temperature for several days on smooth surfaces and several hours on porous surfaces (4).

We used previously described ancestral SARS-CoV-2 (PANGO lineage A) and Omicron VOC (PANGO lineage BA.1) in this study (5,6). We tested their stability on different surfaces using our previously described protocol (4,7). In brief, we applied a 5-μL droplet of each virus (107 50% tissue culture infectious dose [TCID50]/mL) on different surfaces in triplicate. We incubated the treated surfaces at room temperature (21°C–22°C) for different time points as indicated and then immersed them in viral transport medium for 30 min to recover the residual infectious virus. We titrated the recovered virus by TCID50 assays using Vero E6 cells, as described (4,7).

Compared with the ancestral SARS-CoV-2, the Omicron BA.1 variant was more stable on all surfaces we studied (Table). On day 4 postinoculation, we recovered no infectious ancestral SARS-CoV-2 from stainless steel, polypropylene sheet, or 2 of 3 glass samples. We did not recover infectious virus from glass on day 7. In contrast, infectious Omicron variant was still recoverable from all treated surfaces on day 7 postincubation.

The stability of the Omicron variant was also higher than ancestral SARS-CoV-2 on porous surfaces, such as tissue paper and printing paper. On tissue paper, viable ancestral SARS-CoV-2 was no longer recoverable after a 30-minute incubation. However, we detected viable Omicron variant after a 30-minute incubation. On printing paper, we detected no infectious virus after a 15-minute incubation. In contrast, viable Omicron variant was recovered from 2 of 3 replicates after a 30-minute incubation.

To confirm our observations, we used transmembrane serine protease 2 (TMPRSS2)–expressing Vero E6 cells to titrate infectious virus particles recovered from treated stainless steel and printing paper (Appendix Table). On stainless steel, infectious ancestral virus was undetectable on day 10 postincubation, whereas viable Omicron variant was still recoverable. Similarly, no infectious ancestral virus was detected on printing paper after a 30-minute incubation, whereas we detected viable Omicron variant in 1 out of 3 replicates. Although the virus could be trapped in the porous materials and inefficiently recovered, our findings confirm that Omicron variant is more stable than its ancestral strain on surfaces.

We noted that the cell line used for virus titration can affect our findings. It has been reported that Omicron variant is less dependent upon TMPRSS2 for cell entry (8); therefore, we were not surprised that different cell lines led to different viral inactivation profiles. Nonetheless, results from both cell lines suggest that the Omicron variant is more stable than the ancestral strain. This observation is consistent with other recent findings (R. Hirose et al., unpub. data, https://www.biorxiv.org/content/10.1101/2022.01.18.476607v1). More evidence is needed to account for the increased transmissibility of Omicron variant. The virus’s stability on surfaces may be one factor and should be taken into consideration when recommending control measures against infection. A recent study revealed that an infectious dose as low as 10 TCID50 units could infect >50% of human study participants (9). Our findings indicate that Omicron variant has an increased likelihood for transmission by the fomite route; they may also indicate that the enhanced stability deduced from structural studies (3) and now demonstrated on different surfaces may be relevant for droplet or aerosol transmission of SARS-CoV-2. Of interest, stability of avian influenza A(H5N1) viruses has been shown to have an association with transmissibility of avian influenza virus between mammals by the airborne route, although the mechanisms underlying this association are not fully understood (10). Further studies on the stability of Omicron variant and its emerging subvariants in droplets and aerosols are warranted.

One limitation of our study is that the experiments were conducted in a well-controlled laboratory environment. Variations in environmental conditions would affect the rate of viral inactivation. Therefore, the time required for virus inactivation that we demonstrated may not reflect all real-life scenarios. In addition, the components of the viral droplet medium applied in this study were different from those of the respiratory droplets, which could also affect the stability of the virus. Nonetheless, our findings demonstrate that the Omicron variant is more stable than the ancestral SARS-CoV-2 on different surfaces, a finding that may be relevant for determining recommendations for public health measures to limit virus transmission.

Dr. Chin is currently a research assistant professor of the University of Hong Kong. His research interests include basic virology and pathogenesis of emerging respiratory viruses.

Top

Acknowledgment

This work was supported by the Hong Kong Health and Medical Research Fund (no. COVID190116) and Theme-based Research Scheme of Research Grant Council (no. T11-705/21-N), and InnoHK grants for Centre for Immunology & Infection.

Top

References

  1. World Health Organization. Coronavirus update 74: addressing the challenges of SARS-CoV-2 variants for public health. 2022 25 Feb [cited 2022 Apr 29]. https://www.who.int/publications/m/item/update-74-addressing-the-challenges-of-sars-cov-2-variants-for-public-health
  2. Wang  L, Cheng  G. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa. J Med Virol. 2022;94:172833. DOIPubMedGoogle Scholar
  3. Cui  Z, Liu  P, Wang  N, Wang  L, Fan  K, Zhu  Q, et al. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell. 2022;185:860871.e13. DOIPubMedGoogle Scholar
  4. Chin  AWH, Chu  JTS, Perera  MRA, Hui  KPY, Yen  HL, Chan  MCW, et al. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. 2020;1:e10. DOIPubMedGoogle Scholar
  5. Sia  SF, Yan  LM, Chin  AWH, Fung  K, Choy  KT, Wong  AYL, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583:8348. DOIPubMedGoogle Scholar
  6. Cheng  SMS, Mok  CKP, Leung  YWY, Ng  SS, Chan  KCK, Ko  FW, et al. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination. Nat Med. 2022;28:4869. DOIPubMedGoogle Scholar
  7. Behzadinasab  S, Chin  A, Hosseini  M, Poon  L, Ducker  WA. A surface coating that rapidly inactivates SARS-CoV-2. ACS Appl Mater Interfaces. 2020;12:347237. DOIPubMedGoogle Scholar
  8. Meng  B, Abdullahi  A, Ferreira  IATM, Goonawardane  N, Saito  A, Kimura  I, et al.; CITIID-NIHR BioResource COVID-19 Collaboration; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ecuador-COVID19 Consortium. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603:70614. DOIPubMedGoogle Scholar
  9. Killingley  B, Mann  AJ, Kalinova  M, Boyers  A, Goonawardane  N, Zhou  J, et al. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat Med. 2022. DOIPubMedGoogle Scholar
  10. Imai  M, Herfst  S, Sorrell  EM, Schrauwen  EJ, Linster  M, De Graaf  M, et al. Transmission of influenza A/H5N1 viruses in mammals. Virus Res. 2013;178:1520. DOIPubMedGoogle Scholar

Top

Figure
Table

Top

Suggested citation for this article: Chin AWH, Lai AMY, Peiris M, Poon LLM. Increased stability of SARS-CoV-2 Omicron variant over ancestral strain. Emerg Infect Dis. 2022 July [date cited]. https://doi.org/10.3201/eid2807.220428

DOI: 10.3201/eid2807.220428

Original Publication Date: May 12, 2022

Table of Contents – Volume 28, Number 7—July 2022

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Alex Wing Hong Chin, School of Public Health, The University of Hong Kong, Hong Kong

Send To

10000 character(s) remaining.

Top

Page created: May 04, 2022
Page updated: May 12, 2022
Page reviewed: May 12, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external